To validate ADAMTS12 inactivation as a driver of progression in lung carcinoma, we investigated the effect of silencing ADAMTS12 in the lung carcinoma cell line LL/2-luc-M38 using a shRNA plasmid. Here, ADAMTS12 is linked to lung carcinoma.